Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Patel, N. S. A., Paola, R. D., . . . Thiemermann, C. (2003). Rosiglitazone and 15-deoxy-Δ(12,14)-prostaglandin J(2), ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut.
Chicago Stili AlıntıCuzzocrea, Salvatore, et al. Rosiglitazone and 15-deoxy-Δ(12,14)-prostaglandin J(2), Ligands of the Peroxisome Proliferator-activated Receptor-γ (PPAR-γ), Reduce Ischaemia/reperfusion Injury of the Gut. 2003.
MLA AlıntıCuzzocrea, Salvatore, et al. Rosiglitazone and 15-deoxy-Δ(12,14)-prostaglandin J(2), Ligands of the Peroxisome Proliferator-activated Receptor-γ (PPAR-γ), Reduce Ischaemia/reperfusion Injury of the Gut. 2003.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..